Drs. Ryan Brinkman and Peter Stirling awarded Natural Sciences and Engineering Research Council of Canada (NSERC) grants

Congratulations to Dr. Ryan Brinkman on receiving a 5-year NSERC Discovery Grant for his proposal entitled "Automated analysis of high dimensional flow cytometry data" and Dr. Peter Stirling on a 5-year NSERC Discovery Grant and 3-year Discovery Accelerator Supplement (DAS) for his proposal entitled “Nuclear protein quality control mechanisms during genotoxic stress”.

Afsaneh Mojtabanezhad Shariatpanahi awarded Echoridge Educational Foundation Scholarship in Continuing Education of Stem Cell Transplant Research & Development

Congratulations to Afsaneh Mojtabanezhad Shariatpanahi (Kuchenbauer Lab) who has been awarded an Echoridge Educational Foundation Scholarship in Continuing Education of Stem Cell Transplant Research & Development for her project entitled “Elucidating the molecular mechanism of high-risk multiple myeloma”.

Drs. Florian Kuchenbauer, Robert Britton, David Vocadlo and Matthew Nodwell awarded Canadian Cancer Society Innovation Grant

Congratulations to Dr. Florian Kuchenbauer (Kuchenbauer Lab) who recently has been awarded a two-year Canadian Cancer Society Innovation Grant as part of a research team consisted of investigators from Simon Fraser University (Dr. Robert Britton, the Lead PI, and Drs. David Vocadlo and Matthew Nodwell) for their proposal entitled “Small molecule inhibitors of O-GlcNAc transferase: validation of a new anticancer target”.

A new combination treatment targeting “cancer stem cells” may overcome drug resistance in blood cancers

Building on a BC Cancer discovery from decades past, a new combination treatment has shown promise to overcome drug resistance and relapse in people with chronic myeloid leukemia. 

Building off the discovery of an enzyme called integrin-linked kinase (ILK) made by BC Cancer distinguished scientist Dr. Shoukat Dedhar 24 years ago, BC Cancer’s Drs. Xiaoyan Jiang and Shoukat Dedhar have made a significant advancement in understanding the role of this enzyme in blood cancers. 

Back to top